Literature DB >> 6449332

Depressed suppressor cell activity in patients with newly diagnosed insulin-dependent diabetes mellitus.

K Buschard, S Madsbad, J Rygaard.   

Abstract

Suppressor cell activity (SCA) was studied in twenty-eight patients with insulin-dependent diabetes mellitus (IDDM), both newly diagnosed and of longer standing. Suppressive effect of peripheral blood lymphocytes from the patients was tested after 48 hr of incubation with concanavalin A followed by inactivation. Suppression was measured as the ability of the lymphocytes to inhibit 3H-thymidine incorporation in concanavalin A-stimulated normal donor lymphocytes. SCA was expressed in relation to the activity of peripheral blood lymphocytes from simultaneously investigated healthy control individuals. The main findings were: (1) SCA was significantly depressed in newly diagnosed diabetics and (2) newly diagnosed patients displayed significantly lower SCA than did patients with duration of disease between 2 and 8 months and between 5 and 8 years, who had suppressor cell activities not significantly different from healthy individuals. Earlier studies have pointed to the significance of immune reactions in diabetogenesis. On this basis, and on the strength of our present findings, it is suggested that an impaired SCA, causing a decreased inhibition of aggressive lymphocytes, may be implicated in the pathogenesis of insulin-dependent diabetes mellitus.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6449332      PMCID: PMC1536925     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  22 in total

1.  Cell-mediated immunity in diabetes mellitus.

Authors:  J Nerup; O O Andersen; G Bendixen; J Egeberg; R Gunnarsson; H Kromann; J E Poulsen
Journal:  Proc R Soc Med       Date:  1974-06

2.  Islet-cell antibodies in diabetes mellitus with autoimmune polyendocrine deficiencies.

Authors:  G F Bottazzo; A Florin-Christensen; D Doniach
Journal:  Lancet       Date:  1974-11-30       Impact factor: 79.321

3.  Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g.

Authors:  A Böyum
Journal:  Scand J Clin Lab Invest Suppl       Date:  1968

4.  Cell-mediated immunity to human pancreas in diabetes mellitus.

Authors:  A C MacCuish; J Jordan; C J Campbell; L J Duncan; W J Irvine
Journal:  Diabetes       Date:  1974-08       Impact factor: 9.461

5.  Pathologic anatomy of the pancreas in juvenile diabetes mellitus.

Authors:  W Gepts
Journal:  Diabetes       Date:  1965-10       Impact factor: 9.461

6.  Radiosensitivity of suppressor cells in newborn rats.

Authors:  P McCullagh
Journal:  Aust J Exp Biol Med Sci       Date:  1976-10

7.  Cell-mediated immunity in diabetes mellitus; lymphocyte transformation by insulin and insulin fragments in insulin-treated and newly-diagnosed diabetes.

Authors:  A C MacCuish; J Jordan; C J Campbell; L J Duncan; W J Irvine
Journal:  Diabetes       Date:  1975-01       Impact factor: 9.461

8.  Insulin-dependent diabetes: a disease of autoaggression.

Authors:  S W Huang; N K Maclaren
Journal:  Science       Date:  1976-04-02       Impact factor: 47.728

9.  Antibody to cultured human insulinoma cells in insulin-dependent diabetes.

Authors:  N K Maclaren; S W Huang; J Fogh
Journal:  Lancet       Date:  1975-05-03       Impact factor: 79.321

10.  Suppressor cell activity after concanavalin A treatment of lymphocytes from normal donors.

Authors:  L Shou; S A Schwartz; R A Good
Journal:  J Exp Med       Date:  1976-05-01       Impact factor: 14.307

View more
  32 in total

Review 1.  Prospects for the prevention and reversal of type 1 diabetes mellitus.

Authors:  Nikolai Petrovsky; Diego Silva; Desmond A Schatz
Journal:  Drugs       Date:  2002       Impact factor: 9.546

Review 2.  Lymphocyte subpopulations.

Authors:  R J Powell; J S Jenkins
Journal:  Postgrad Med J       Date:  1987-11       Impact factor: 2.401

3.  Immunoregulatory dysfunctions in type I diabetes: natural and antibody-dependent cellular cytotoxic activities.

Authors:  M P Nair; E W Lewis; S A Schwartz
Journal:  J Clin Immunol       Date:  1986-09       Impact factor: 8.317

Review 4.  Multiple immunological abnormalities in patients with type 1 (insulin-dependent) diabetes mellitus.

Authors:  D W Drell; A L Notkins
Journal:  Diabetologia       Date:  1987-03       Impact factor: 10.122

5.  In vivo administration of serum thymic factor (FTS) prevents EMC-D virus-induced diabetes and myocarditis in BALB/cAJcl mice.

Authors:  M Mizutani; M El-Fotoh; M Mori; K Ono; K Doi; A Awaya; Y Matsumoto; Y Matsumoto; T Onodera
Journal:  Arch Virol       Date:  1996       Impact factor: 2.574

6.  Virus-induced diabetes mellitus in mice and the thymus-dependent immune system.

Authors:  K Buschard; N Hastrup; J Rygaard
Journal:  Diabetologia       Date:  1983-01       Impact factor: 10.122

7.  Lymphocyte transfusions prevent diabetes in the Bio-Breeding/Worcester rat.

Authors:  A A Rossini; D Faustman; B A Woda; A A Like; I Szymanski; J P Mordes
Journal:  J Clin Invest       Date:  1984-07       Impact factor: 14.808

Review 8.  The role of immunotherapy in type I diabetes mellitus.

Authors:  M E Geffner; B M Lippe
Journal:  West J Med       Date:  1987-03

9.  Antibody-dependent and natural killer cytotoxicity in type 1 diabetes.

Authors:  M Sensi; P Pozzilli; A G Cudworth
Journal:  Acta Diabetol Lat       Date:  1981 Oct-Dec

10.  Immunoregulatory T-lymphocyte subset deficiency in newly diagnosed type 1 (insulin-dependent) diabetes mellitus.

Authors:  A Galluzzo; C Giordano; G Rubino; G D Bompiani
Journal:  Diabetologia       Date:  1984-06       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.